Cargando…
Efficacy and Safety of Novel Oral P2Y(12) Receptor Inhibitors in Patients With ST-Segment Elevation Myocardial Infarction Undergoing PCI: A Systematic Review and Meta-Analysis
The efficacy and safety of novel oral P2Y(12) receptor inhibitors (prasugrel and ticagrelor) are subjects of contention in patients with ST-segment elevation myocardial infarction (STEMI) undergoing PCI, and the optimal duration of therapy remains uncertain. We searched PubMed, Embase, Cochrane Libr...
Autores principales: | Sun, Jianjun, Xiang, Qian, Li, Chao, Wang, Zining, Hu, Kun, Xie, Qiufen, Cui, Yimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Cardiovascular Pharmacology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578732/ https://www.ncbi.nlm.nih.gov/pubmed/28045759 http://dx.doi.org/10.1097/FJC.0000000000000459 |
Ejemplares similares
-
The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI
por: Kostic, Jelena, et al.
Publicado: (2015) -
Safety of Bivalirudin Combined with Ticagrelor in the Emergency PCI in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Wang, Zheng-Dong, et al.
Publicado: (2022) -
Analysis of the Best Timing for Applying Tirofiban in PCI Operation for the Patients with ST Segment Elevation Myocardial Infarction
por: Lei, Zhang, et al.
Publicado: (2015) -
Primary PCI versus pharmacoinvasive strategy for ST elevation myocardial infarction
por: Helal, Ayman M., et al.
Publicado: (2018) -
Erythropoietin Reduces Post-PCI Arrhythmias in Patients With ST-elevation Myocardial Infarction
por: Gholamzadeh, Ali, et al.
Publicado: (2015)